WILLIAMS JONES & ASSOCIATES LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
WILLIAMS JONES & ASSOCIATES LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2019$686,000
-17.8%
5,700
-40.3%
0.01%
-22.2%
Q1 2019$835,000
+271.1%
9,550
+324.4%
0.02%
+200.0%
Q4 2018$225,000
-12.8%
2,2500.0%0.01%
+20.0%
Q3 2018$258,000
-12.8%
2,250
-44.4%
0.01%
-28.6%
Q1 2018$296,0004,0500.01%
Other shareholders
HAEMONETICS CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders